Hypothalamic hamartoma presenting as central precocious puberty in a girl: a case report

Soumya Ranjan Mohanty

doi:10.18203/2349-3291.ijcp20253492

Authors

Soumya Ranjan Mohanty Department of Endocrinology & Metabolism, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20253492

Keywords:

Central precocious puberty, GnRH-dependent precocity, Hypothalamic hamartoma

Abstract

Central precocious puberty (CPP) is defined as the early onset of secondary sexual characteristics due to premature activation of the hypothalamic pituitary gonadal (HPG) axis. Hypothalamic hamartomas are rare but classical causes of CPP. We report a case of a 2 years 7 months old girl with progressive breast enlargement and pubic hair development, found to have a hypothalamic hamartoma on MRI.

Metrics

Metrics Loading ...

References

Carel JC, Léger J. Precocious puberty. New England J Med. 2008;358(22):2366-77. DOI: https://doi.org/10.1056/NEJMcp0800459

Sinokrot J, Dakkak H, Qasem A, Sharif G, Itmaiza M, Abu-Libdeh A. Exaggerated Mini-puberty in a Premature Female: Addressing the Treatment Dilemma in the Face of Vaginal Bleeding. 2025. DOI: https://doi.org/10.21203/rs.3.rs-5982924/v1

Teilmann G, Pedersen CB, Jensen TK, Skakkebaek NE, Juul A. Prevalence and incidence of precocious pubertal development in Denmark: An epidemiologic study based on national registries. Pediatrics. 2005;116:1323–8. DOI: https://doi.org/10.1542/peds.2005-0012

Fuqua JS. Treatment and outcomes of precocious puberty: An update. J Clin Endocrinol Metab. 2013;98:2198–207. DOI: https://doi.org/10.1210/jc.2013-1024

Castro C, Morais JM, Correia AL, Espada F. Hypothalamic hamartoma: a cause of precocious puberty. BMJ Case Reports CP. 2023;16(3):254429. DOI: https://doi.org/10.1136/bcr-2022-254429

Harrison VS, Oatman O, Kerrigan JF. Hypothalamic hamartoma with epilepsy: Review of endocrine comorbidity. Epilepsia. 2017;58(2):50-9. DOI: https://doi.org/10.1111/epi.13756

Harrington J, Palmert MR, Hamilton J. Use of local data to enhance uptake of published recommendations: an example from the diagnostic evaluation of precocious puberty. Arch Dis Childhood. 2014;99:15-20. DOI: https://doi.org/10.1136/archdischild-2013-304414

Arita K, Kurisu K, Kiura Y, Iida K, Otsubo H. Hypothalamic hamartoma. Neurol Med Chir. 2005;45(5):221-31. DOI: https://doi.org/10.2176/nmc.45.221

Freeman JL, Coleman LT, Wellard RM, Kean MJ, Rosenfeld JV, Jackson GD, et al. MR imaging and spectroscopic study of epileptogenic hypothalamic hamartomas: analysis of 72 cases. AJNR Am J Neuroradiol. 2004;25(3):450-62.

Neely EK, Hintz RL, Parker B, Bachrach LK, Cohen P, Olney R, et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediat. 1992;121(4):634-40. DOI: https://doi.org/10.1016/S0022-3476(05)81162-X

Latronico AC, Brito VN, Carel JC. Causes, diagnosis and treatment of central precocious puberty. Lancet Diab Endocrinol. 2016;1;4(3):265-74. DOI: https://doi.org/10.1016/S2213-8587(15)00380-0

Kim SJ, Kim JH, Hong YH, Chung IH, Lee EB, Kang E, et al. Clinical practice guidelines for central precocious puberty of Korean children and adolescents. Ann Ped Endocrinol Metabol. 2023;28(3):168-77. DOI: https://doi.org/10.6065/apem.2346168.084